GenusPlus Group Ltd (ASX:GNP) has applied to ASX for quotation of 114,576 fully paid ordinary shares issued on 12 November 2026 under the company's tax exempt employee share scheme, at an issue price of AUD $8.01 per share.

Key Points

  • 114,576 fully paid ordinary GNP shares to be quoted, issued on 12 November 2026
  • Issue price of AUD $8.01 per share, based on the volume weighted average share price over the 10 business days up to and including 4 November 2026
  • Shares issued under GenusPlus Group's tax exempt employee share scheme, with eligible employees receiving up to $1,000 of shares
  • Key Management Personnel did not participate in the scheme
  • Following quotation, total quoted ordinary shares on issue will be 204,209,625

Tax Exempt Employee Share Scheme Terms

Under GenusPlus Group's tax exempt employee share scheme, eligible employees were issued with up to $1,000 worth of fully paid ordinary GNP shares each. The issue price of $8.01 per share was calculated as the volume weighted average share price of GNP shares over the 10 business days up to and including 4 November 2026. The filing states that Key Management Personnel did not participate in the scheme. The securities are issued under Listing Rule 7.2 exception 13 and therefore did not require securityholder approval under Listing Rule 7.1.

Dealing Restrictions on Issued Shares

According to the filing, employees receiving shares under the scheme will not be permitted to deal with their shares for three years from the date the shares are acquired, or until the employee ceases to be an employee of GenusPlus Group Ltd or a company that is a related body corporate. The filing states the new securities will rank equally in all respects from their issue date with the existing issued securities in the same class. The shares are being issued for cash consideration in Australian dollars.

Issued Capital Following Quotation

Following quotation of the 114,576 ordinary shares, the total number of quoted ordinary fully paid GNP securities on issue will be 204,209,625. The company also has unquoted securities on issue, comprising 1,195,518 performance rights (GNPAB), 1,153,126 share appreciation rights (GNPAC), and 35,914 retention rights (GNPAA), according to the filing. The application for quotation was lodged with ASX on 19 November 2026.